Ade decreases cell viability and induces cell death. by Shujue Li (466324)

Exposure to CS decreased levels of the anti-apoptotic Bcl-2 and Mcl-1 molecules in macrophages. by Leslie Chávez-Galán (489001)

Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. by Haiyang Dong (4783608)

Image_5_Frequency of Systemic Lupus Erythematosus Was Decreasing Among Hospitalized Patients From 2013 to 2017 in a National Database in China.JPEG by Ying Tan (346135)

Pregnancy-induced decrease in maternal serum BUN and IFN- by Haruka Mizobuchi (5395394)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

CONSORT flow diagram. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

Adverse events in placebo arm. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

“…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”

Intraperitoneal injection protocol for inhibitors (A), inhibitors DAS and Y27632 reduced intestinal permeability (B) and intestinal adult worm burden (C) of infected mice. by Wen Wen Zheng (17721404)

“…<b>B:</b> DAS and Y27632 decreased the blood plasma FD-4 content increase caused by <i>T. spiralis</i> infection. …”

Decreased sperm production in <i>Arf</i>-null mice is compensated by loss of <i>Ink4a</i> or <i>p53</i>. by Michelle L. Churchman (347537)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

Postnatal CDPPB treatment decreased [¹¹C]PBR accumulation in saline-exposed offspring, but not in offspring prenatally exposed to LPS. by Dany Arsenault (229311)

“…Values are expressed as mean ± SEM. Abbreviations: CDPPB, 3-cyano-<i>N</i>-(1,3-diphenyl-1<i>H</i>-pyrazol-5-yl)benzamide; [¹¹C] PBR28, peripheral benzodiazepine receptor 28; Ctx, cortex; Crbl, cerebellum; Hip, hippocampus; Hth, hypothalamus; OB, olfactory bulb; PnD, postnatal day; Str, striatum; W, whole brain. …”

Epidermal GATA3 expression is decreased in psoriatic lesions. by Emőke Rácz (220871)

Kisspeptin-10 decreases blood flow in the peripheral vasculature. by Iain Sawyer (356468)

APC decreases epithelial cytotoxicity induced by histones but not by NET. by Mona Saffarzadeh (180792)

Germ cell size decreases before corpse formation. by Tea Kohlbrenner (19476160)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75^NTR-siRNA and p75^NTR/trkA^NGFR-siRNA (p<.05).…”

VPA treatment and senescence induction is associated with decreased neurogenesis. by Muriel Rhinn (406515)

Diclofenac decreases glucose consumption and modulates lactate accumulation. by Eva Gottfried (431785)